Bioequivalence and Pharmacokinetics Comparison of Two Formulations of Extended-Release Pentoxifylline Tablets in Healthy Subjects after Fasting and Fed Conditions
The pharmacokinetics and bioequivalence of a newly developed extended-released (ER) tablet containing 400 mg pentoxifylline as a test product was compared with the reference brand product Trental® 400 mg ER tablet produced by Sanofi-Aventis. Two separate studies were conducted simultaneously. The f...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy University of Baghdad
2017-03-01
|
Series: | Iraqi Journal of Pharmaceutical Sciences |
Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/367 |